Measurement of Epstein-Barr virus DNA load using a novel quantification standard containing two EBV DNA targets and SYBR Green i dye

Virology Journal

Volumn 7, Issue , 2010, Pages

  Lay, Meav Lang J ^a   Lucas, Robyn M ^b   Ratnamohan, Mala ^a   Taylor, Janette ^a   Ponsonby, Anne Louise ^c   Dwyer, Dominic E ^a  

^a WESTMEAD HOSPITAL   (Australia)

^b The Australian National University   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DYE; EDETIC ACID; EPSTEIN BARR VIRUS ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; SYBR GREEN I; UNCLASSIFIED DRUG; VIRUS CAPSID ANTIGEN; VIRUS DNA; IMMUNOGLOBULIN G; ORGANIC COMPOUND; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DNA DETERMINATION; EPSTEIN BARR VIRUS; FEMALE; HEMOPHAGOCYTIC SYNDROME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOCOMPROMISED PATIENT; INFECTIOUS MONONUCLEOSIS; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PERIPHERAL BLOOD MONONUCLEAR CELL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STANDARD; VIRUS GENE; VIRUS LOAD; VIRUS REACTIVATION; BLOOD; EPSTEIN BARR VIRUS INFECTION; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; MIDDLE AGED; MONONUCLEAR CELL; PLASMA; STAINING; VIROLOGY;

HUMAN HERPESVIRUS 4; MIRIDAE;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; BLOOD; CEREBROSPINAL FLUID; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN G; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; ORGANIC CHEMICALS; PLASMA; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY; STAINING AND LABELING; VIRAL LOAD; YOUNG ADULT;

EID: 77956858734     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-252     Document Type: Article

References (75)

1. Epstein-Barr virus latent infection in vivo. NM Steven, Rev Med Virol 1997 7 2 97 106 10.1002/(SICI)1099-1654(199707)7:2<97::AID-RMV190>3.0. CO;2-M 10398475
2. Routine Epstein-Barr virus diagnostics from the laboratory perspective: still challenging after 35 years. RD Hess, J Clin Microbiol 2004 42 8 3381 7 10.1128/JCM.42.8.3381-3387.2004 15297472
3. EBV PCR in the diagnosis and monitoring of posttransplant lymphoproliferative disorder: results of a two-arm prospective trial. DE Tsai, et al. Am J Transplant 2008 8 5 1016 24 10.1111/j.1600-6143.2008.02183.x 18312608
4. Monitoring of EBV-DNAemia by quantitative real-time PCR after adult liver transplantation. R Loginov, et al. J Clin Virol 2006 37 2 104 108 10.1016/j.jcv.2006.06.012 16931140
5. Herpesviruses. MC Timbury E Edmond, J Clin Pathol 1979 32 9 859 81 10.1136/jcp.32.9.859 229129
6. Epstein-Barr virus infection. JI Cohen, N Engl J Med 2000 343 7 481 92 10.1056/NEJM200008173430707 10944566
7. Viral load in Epstein-Barr virus-associated hemophagocytic syndrome. H Kimura, et al. Microbiol Immunol 2002 46 8 579 82 12363023
8. High Epstein-Barr virus (EBV) DNA loads in HIV-infected patients: correlation with antiretroviral therapy and quantitative EBV serology. SJ Stevens, et al. AIDS 2002 16 7 993 1001 10.1097/00002030-200205030-00005 11953465
9. Comparison of three methods for extraction of viral nucleic acids from blood cultures. MJ Espy, et al. J Clin Microbiol 1995 33 1 41 4 7699063
10. Dynamic EBV gene loads in renal, hepatic, and cardiothoracic transplant recipients as determined by real-time PCR light cycler. E Leung, et al. Transpl Infect Dis 2004 6 4 156 64 10.1111/j.1399-3062.2004.00073.x 15762933
11. Quantitative polymerase chain reaction for human herpesvirus diagnosis and measurement of Epstein-Barr virus burden in posttransplant lymphoproliferative disorder. X Bai, et al. Clin Chem 1997 43 10 1843 9 9342002
12. Evaluation of a commercial real-time PCR assay for quantitation of Epstein-Barr virus DNA in different groups of patients. S Kozic, et al. J Virol Methods 2006 135 2 263 8 Epub 2006 May 2 10.1016/j.jviromet.2006.03.013 16650904
13. Toward standardization of Epstein-Barr virus DNA load monitoring: unfractionated whole blood as preferred clinical specimen. SJ Stevens I Pronk JM Middeldorp, J Clin Microbiol 2001 39 4 1211 6 10.1128/JCM.39.4.1211-1216.2001 11283029
14. Use of real-time PCR to measure Epstein-Barr virus genomes in whole blood. E Leung, et al. J Immunol Methods 2002 270 2 259 67 12379330
15. Epstein-Barr virus quantitation by real-time PCR targeting multiple gene segments: a novel approach to screen for the virus in paraffin-embedded tissue and plasma. JL Ryan, et al. J Mol Diagn 2004 6 4 378 85 15507678
16. Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. DT Rowe, et al. J Clin Microbiol 1997 35 6 1612 5 9163497
17. Epstein-Barr viral load measurement as a marker of EBV-related disease. H Fan ML Gulley, Mol Diagn 2001 6 4 279 89 11774193
18. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. H Kimura, et al. J Clin Microbiol 1999 37 1 132 6 9854077
19. Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. YM Lo, et al. Cancer Res 1999 59 21 5452 5 10554016
20. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. YM Lo, et al. Cancer Res 1999 59 6 1188 91 10096545
21. Role of Epstein-Barr virus DNA load monitoring in prevention and early detection of post-transplant lymphoproliferative disease. SJ Stevens, et al. Leuk Lymphoma 2002 43 4 831 40 10.1080/10428190290016971 12153173
22. Development of a real-time quantitative assay for detection of Epstein-Barr virus. HGM Niesters, et al. J Clin Microbiol 2000 38 2 712 5 10655372
23. A comparison of quantitative-competitive and realtime PCR assays using an identical target sequence to detect Epstein-Barr virus viral load in the peripheral blood. S Xu, et al. J Virol Methods 2006 137 2 205 12 10.1016/j.jviromet.2006.06.012 16879878
24. Routine use of real-time quantitative PCR for laboratory diagnosis of Epstein-Barr virus infections. K Brengel-Pesce, et al. J Med Virol 2002 66 3 360 9 10.1002/jmv.2153 11793388
25. Real-time PCR in virology. IM Mackay KE Arden A Nitsche, Nucleic Acids Res 2002 30 6 1292 305 10.1093/nar/30.6.1292 11884626
26. Evaluation of the Epstein-Barr virus R-gene quantification kit in whole blood with different extraction methods and PCR platforms. S Fafi-Kremer, et al. J Mol Diagn 2008 10 1 78 84 10.2353/jmoldx.2008.070054 18165270
27. Comparison of commercial real-time PCR assays for quantification of Epstein-Barr virus DNA. G Ruiz, et al. J Clin Microbiol 2005 43 5 2053 7 10.1128/JCM.43.5.2053-2057.2005 15872221
28. SYBR green-based real-time quantitative PCR assay for detection of West Nile Virus circumvents false-negative results due to strain variability. JF Papin W Vahrson DP Dittmer, J Clin Microbiol 2004 42 4 1511 8 10.1128/JCM.42.4.1511-1518.2004 15070997
29. SYBR green I DNA staining increases the detection sensitivity of viruses by polymerase chain reaction. F Karlsen HB Steen JM Nesland, J Virol Methods 1995 55 1 153 6 10.1016/0166-0934(95)00053-W 8576305
30. Faster quantitative real-time PCR protocols may lose sensitivity and show increased variability. C Hilscher W Vahrson DP Dittmer, Nucleic Acids Res 2005 33 21 182. 10.1093/nar/gni181 16314296
31. Associations between silicone skin cast score, cumulative sun exposure, and other factors in the ausimmune study: a multicenter Australian study. RM Lucas, et al. Cancer Epidemiol Biomarkers Prev 2009 18 11 2887 94 10.1158/1055-9965.EPI-09-0191 19843682
32. The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold. S Humme, et al. Proc Natl Acad Sci USA 2003 100 19 10989 94 10.1073/pnas.1832776100 12947043
33. Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virus. MA Lee ME Diamond JL Yates, J Virol 1999 73 4 2974 82 10074147
34. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. S Henderson, et al. Proc Natl Acad Sci USA 1993 90 18 8479 83 10.1073/pnas.90.18.8479 8397406
35. Proper developmental control of human globin genes reproduced by transgenic mice containing a 160-kb BAC carrying the human beta-globin locus. Y Huang, et al. Blood Cells Mol Dis 2000 26 6 598 610 10.1006/bcmd.2000.0339 11358351
36. Comparison of various blood compartments and reporting units for the detection and quantification of Epstein-Barr virus in peripheral blood. H Hakim, et al. J Clin Microbiol 2007 45 7 2151 5 10.1128/JCM.02308-06 17494720
37. Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation. JW van Esser, et al. Br J Haematol 2001 113 3 814 21 10.1046/j.1365-2141.2001.02789.x 11380475
38. Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients. SJ Stevens, et al. Blood 2001 97 5 1165 71 10.1182/blood.V97.5.1165 11222357
39. Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation. KG Lucas, et al. Blood 1998 91 10 3654 61 9573001
40. Measuring Epstein-Barr virus (EBV) load: the significance and application for each EBV-associated disease. H Kimura, et al. Rev Med Virol 2008 18 5 305 19 10.1002/rmv.582 18494041
41. Post-transplantation lymphoproliferative disease: Epstein-Barr virus DNA levels, HLA-A3, and survival. SA Wheless, et al. Am J Respir Crit Care Med 2008 178 10 1060 5 10.1164/rccm.200804-531OC 18755927
42. Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients. KC Chan, et al. Cancer Res 2003 63 9 2028 32 12727814
43. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. JC Lin, et al. N Engl J Med 2004 350 24 2461 70 10.1056/NEJMoa032260 15190138
44. Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection. CC Bauer, et al. J Med Virol 2005 75 1 54 8 10.1002/jmv.20237 15543583
45. Quantification of Epstein-Barr virus load in peripheral blood of human immunodeficiency virus-infected patients using real-time PCR. A Dehee, et al. J Med Virol 2001 65 3 543 52 10.1002/jmv.2071 11596092
46. Detection and quantification of virus DNA in plasma of patients with Epstein-Barr virus-associated diseases. M Yamamoto, et al. J Clin Microbiol 1995 33 7 1765 8 7665644
47. Patients at risk for development of posttransplant lymphoproliferative disorder: plasma versus peripheral blood mononuclear cells as material for quantification of Epstein-Barr viral load by using real-time quantitative polymerase chain reaction. HJ Wagner, et al. Transplantation 2001 72 6 1012 9 10.1097/00007890-200109270-00006 11579293
48. Epstein-Barr virus load monitoring: its role in the prevention and management of post-transplant lymphoproliferative disease. DT Rowe, et al. Transpl Infect Dis 2001 3 2 79 87 10.1034/j.1399-3062.2001.003002079.x 11395973
49. Associations of serum EBV DNA and gammopathy with post-transplant lymphoproliferative disease. A Rosselet, et al. Clin Transplant 2009 23 1 74 82 10.1111/j.1399-0012.2008.00904.x 19200218
50. Simultaneous quantification of Epstein-Barr virus, cytomegalovirus, and human herpesvirus 6 DNA in samples from transplant recipients by multiplex real-time PCR assay. K Wada, et al. J Clin Microbiol 2007 45 5 1426 32 10.1128/JCM.01515-06 17376882
51. Epstein-Barr virus DNA load in cerebrospinal fluid and plasma of patients with AIDS-related lymphoma. S Bossolasco, et al. J Neurovirol 2002 8 5 432 8 10.1080/13550280260422730 12402169
52. Monitoring of epstein-barr virus DNA load in peripheral blood by quantitative competitive PCR. SJ Stevens, et al. J Clin Microbiol 1999 37 9 2852 7 10449464
53. Epstein-Barr viral load assessment in immunocompetent patients with fulminant infectious mononucleosis. JA van Laar, et al. Arch Intern Med 2002 162 7 837 9 10.1001/archinte.162.7.837 11926861
54. Severe Epstein-Barr virus-associated hemophagocytic syndrome in six adult patients. AS Elazary, et al. J Clin Virol 2007 40 2 156 9 10.1016/j.jcv.2007. 06.014 17703994
55. Quantitative analysis of cell-free Epstein-Barr virus genome copy number in patients with EBV-associated hemophagocytic lymphohistiocytosis. T Teramura, et al. Leuk Lymphoma 2002 43 1 173 9 10.1080/10428190210176 11908724
56. Multiplex real-time PCR for the detection and quantification of latent and persistent viral genomes in cellular or plasma blood fractions. LI Compston, et al. J Virol Methods 2008 151 1 47 54 10.1016/j.jviromet.2008.03.023 18479760
57. Comparison of serum and whole blood levels of cytomegalovirus and Epstein-Barr virus DNA. C Kullberg-Lindh, et al. Transpl Infect Dis 2008 10 5 308 15 10.1111/j.1399-3062.2008.00313.x 18466193
58. Herpesvirus prevalence and viral load in healthy blood donors by quantitative real-time polymerase chain reaction. SD Hudnall, et al. Transfusion 2008 48 6 1180 7 10.1111/j.1537-2995.2008.01685.x 18422852
59. Rapid quantitative PCR assays for the simultaneous detection of herpes simplex virus, varicella zoster virus, cytomegalovirus, Epstein-Barr virus, and human herpesvirus 6 DNA in blood and other clinical specimens. I Engelmann, et al. J Med Virol 2008 80 3 467 77 10.1002/jmv.21095 18205230
60. Positive correlation between Epstein-Barr virus viral load and anti-viral capsid immunoglobulin G titers determined for Hodgkin's lymphoma patients and their relatives. C Besson, et al. J Clin Microbiol 2006 44 1 47 50 10.1128/JCM.44.1.47-50.2006 16390946
61. Assessment of automated DNA extraction coupled with real-time PCR for measuring Epstein-Barr virus load in whole blood, peripheral mononuclear cells and plasma. S Fafi-Kremer, et al. J Clin Virol 2004 30 2 157 64 10.1016/j.jcv.2003.10.002 15125872
62. Normalized quantification by real-time PCR of Epstein-Barr virus load in patients at risk for posttransplant lymphoproliferative disorders. WJ Jabs, et al. J Clin Microbiol 2001 39 2 564 9 10.1128/JCM.39.2.564-569.2001 11158107
63. Measurement of Epstein-Barr virus DNA loads in whole blood and plasma by TaqMan PCR and in peripheral blood lymphocytes by competitive PCR. RM Wadowsky, et al. J Clin Microbiol 2003 41 11 5245 9 10.1128/JCM.41.11.5245-5249.2003 14605174
64. Kinetics of Epstein-Barr virus DNA load in different blood compartments of pediatric recipients of T-cell-depleted HLA-haploidentical stem cell transplantation. F Baldanti, et al. J Clin Microbiol 2008 46 11 3672 7 10.1128/JCM.00913-08 18799701
65. Comparison of manual and automated nucleic acid extraction from whole-blood samples. K Riemann, et al. J Clin Lab Anal 2007 21 4 244 8 10.1002/jcla.20174 17621359
66. Reduced PCR sensitivity due to impaired DNA recovery with the MagNA Pure LC total nucleic acid isolation kit. T Schuurman, et al. J Clin Microbiol 2005 43 9 4616 22 10.1128/JCM.43.9.4616-4622.2005 16145116
67. The scope of quantitative polymerase chain reaction assays in clinical molecular pathology. RD Malcomson, et al. Clin Mol Pathol 1995 48 4 178 M183 10.1136/mp.48.4.M178 16696001
68. DNA isolation by a rapid method from human blood samples: effects of MgCl2, EDTA, storage time, and temperature on DNA yield and quality. DK Lahiri B Schnabel, Biochem Genet 1993 31 7-8 321 8 10.1007/BF02401826 8274138
69. Diagnostic value of measuring Epstein-Barr virus (EBV) DNA load and carcinoma-specific viral mRNA in relation to anti-EBV immunoglobulin A (IgA) and IgG antibody levels in blood of nasopharyngeal carcinoma patients from Indonesia. SJ Stevens, et al. J Clin Microbiol 2005 43 7 3066 73 10.1128/JCM.43.7.3066-3073.2005 16002393
70. Validation of Roche LightCycler Epstein-Barr virus quantification reagents in a clinical laboratory setting. ML Gulley H Fan SH Elmore, J Mol Diagn 2006 8 5 589 97 10.2353/jmoldx.2006.050152 17065428
71. Practical Considerations for the Design of Quantitative PCR Assays. D Diaco, PCR Strategies Academic Press Limited, London, G DH, S JJ, Innis MA, 1995 84 107 full-text
72. Quantitative real-time polymerase chain reaction for evaluating DNAemia due to cytomegalovirus, Epstein-Barr virus, and BK virus in solid-organ transplant recipients. TF Smith, et al. Clin Infect Dis 2007 45 8 1056 61 10.1086/521909 17879925
73. Multicenter comparison of different real-time PCR assays for quantitative detection of Epstein-Barr virus. RT Hayden, et al. J Clin Microbiol 2008 46 1 157 63 10.1128/JCM.01252-07 17989187
74. Comparison of commercial and in-house Real-time PCR assays for quantification of Epstein-Barr virus (EBV) DNA in plasma. F Perandin, et al. BMC Microbiol 2007 7 22 10.1186/1471-2180-7-22 17391518
75. Comparative evaluation of a commercially available automated system for extraction of viral DNA from whole blood: application to monitoring of epstein-barr virus and cytomegalovirus load. S Pillet T Bourlet B Pozzetto, J Clin Microbiol 2009 47 11 3753 5 10.1128/JCM.01497-09 19710270